首页> 外文期刊>Central European Journal of Chemistry >Simultaneous chiral separation and determination of carvedilol and 5'-hydroxyphenyl carvedilol enantiomers from human urine by high performance liquid chromatography coupled with fuorescent detection
【24h】

Simultaneous chiral separation and determination of carvedilol and 5'-hydroxyphenyl carvedilol enantiomers from human urine by high performance liquid chromatography coupled with fuorescent detection

机译:高效液相色谱-荧光检测法同时手性分离尿中卡维地洛和5'-羟基苯基卡维地洛对映体

获取原文
获取原文并翻译 | 示例
           

摘要

A sensitive and specifc high performance liquid chromatography coupled with fuorescent detection (HPLC-FL) and tandem mass spectrometry detection (HPLC-MS/MS) methods for separation and determination of carvedilol (CAR) enantiomers and 5'-hydroxyphenyl carvedilol (5'-HCAR) enantiomers has been developed and validated. The analysed compounds were extracted from human urine by solid phase extraction. Good enantioseparation of the studied enantiomers was achieved on CHIRALCEL? OD-RH column using 0.05% trifuoroacetic acid and 0.05% diethylamine in water and acetonitrile in a gradient elution. The mass spectrometric data were acquired using the multiple reaction monitoring mode by positive electrospray ionisation. The method was validated over the concentration range from 25.0 ng mL~(-1) to 200 ng mL~(-1) for the analysed compounds. The limit of quantifcation varied from 14.2 ng mL~(-1) to 24.2 ng mL~(-1) . Both the repeatability and inter-day precisions were below 10.0%, and the accuracy varied from -13.2% to 3.77%. The extraction recoveries ranged from 79.2% to 108%. The present paper repor ts the method for the simultaneous determination of CAR enantiomers and their metabolite enantiomers (5'-HCAR) in human urine samples. This newly developed method was successfully used to analyse the aforementioned analytes in human urine samples obtained from patients suffering from cardiovascular disease.
机译:灵敏且高效的液相色谱结合荧光检测(HPLC-FL)和串联质谱检测(HPLC-MS / MS)方法分离和测定卡维地洛(CAR)对映异构体和5'-羟基苯基卡维地洛(5'- HCAR)对映异构体已开发并验证。通过固相萃取从人尿中提取分析的化合物。在CHIRALCEL上获得了良好的对映异构体对映体OD-RH色谱柱,使用0.05%三氟乙酸和0.05%二乙胺的水和乙腈溶液进行梯度洗脱。通过正电喷雾电离,使用多反应监测模式获取质谱数据。对于所分析化合物,该方法在25.0 ng mL〜(-1)至200 ng mL〜(-1)的浓度范围内得到验证。定量限从14.2 ng mL〜(-1)到24.2 ng mL〜(-1)不等。重复性和日间精度均低于10.0%,精度从-13.2%到3.77%不等。提取回收率在79.2%至108%之间。本文提出了同时测定人尿液样品中CAR对映体及其代谢物对映体(5'-HCAR)的方法。这种新开发的方法已成功用于分析从患有心血管疾病的患者获得的人尿液样品中的上述分析物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号